Treatment of inherited homocystinurias

Neuropediatrics

Volumn 43, Issue 6, 2012, Pages 295-304

  Schiff, Manuel ^a   Blom, Henk J ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cystathionine synthase deficiency; homocystinurias; remethylation disorders

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; CYSTEINE; FOLIC ACID; HYDROXOCOBALAMIN; METHIONINE; PYRIDOXINE; RIBOFLAVIN;

CLINICAL FEATURE; GENETIC DISORDER; HOMOCYSTINURIA; HUMAN; INHERITED HOMOCYSTINURIA; METABOLISM; METHYLATION; NEWBORN SCREENING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

BETAINE; DIET; HOMOCYSTINURIA; HUMANS;

EID: 84870236113     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0032-1329883     Document Type: Review

References (68)

1. Castro R., Rivera I., Blom H. J., Jakobs C., Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis: 2006; 29 1 3 20
2. Yap S., Naughten E. R., Wilcken B., Wilcken D. E., Boers G. H. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost: 2000; 26 3 335 340
3. Wilcken D. E., Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis: 1997; 20 2 295 300 (Pubitemid 27273492)
4. Quadros E. V. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol: 2010; 148 2 195 204
5. Watkins D., Rosenblatt D. S. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet: 2011; 157 1 33 44
6. Watkins D., Rosenblatt D. S. Update and new concepts in vitamin responsive disorders of folate transport and metabolism. J Inherit Metab Dis: 2012; 35 4 665 670
7. Mudd S. H., Cantoni G. L. Activation of methionine for transmethylation. III. The methionine-activating enzyme of Bakers' yeast. J Biol Chem: 1958; 231 1 481 492
8. Li Y. N., Gulati S., Baker P. J., Brody L. C., Banerjee R., Kruger W. D. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet: 1996; 5 12 1851 1858 (Pubitemid 26413626)
9. Sunden S. L., Renduchintala M. S., Park E. I., Miklasz S. D., Garrow T. A. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys: 1997; 345 1 171 174 (Pubitemid 27374220)
10. Finkelstein J. D. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med: 2007; 45 12 1694 1699 (Pubitemid 350232969)
11. Mattson M. P., Shea T. B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci: 2003; 26 3 137 146 (Pubitemid 36183675)
12. Surtees R. Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr: 1998; 157 02 S118 S121
13. Carrillo-Carrasco N., Chandler R. J., Venditti C. P. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis: 2012; 35 1 91 102
14. Hannibal L., Kim J., Brasch N. E., et al. Processing of alkylcobalamins in mammalian cells: a role for the MMACHC (cblC) gene product. Mol Genet Metab: 2009; 97 4 260 266
15. Kim J., Gherasim C., Banerjee R. Decyanation of vitamin B12 by a trafficking chaperone. Proc Natl Acad Sci USA: 2008; 105 38 14551 14554
16. Carrillo-Carrasco N., Venditti C. P. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes. J Inherit Metab Dis: 2012; 35 1 103 114
17. Martinelli D., Deodato F., Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis: 2011; 34 1 127 135
18. Mudd S. H., Skovby F., Levy H. L., et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet: 1985; 37 1 1 31 (Pubitemid 15138674)
19. Walter J. H., Wraith J. E., White F. J., Bridge C., Till J. Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr: 1998; 157 02 S71 S76
20. Ogier de Baulny H., Gérard M., Saudubray J. M., Zittoun J. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr: 1998; 157 02 S77 S83 (Pubitemid 128684222)
21. Weisfeld-Adams J. D., Morrissey M. A., Kirmse B. M., et al. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol Genet Metab: 2010; 99 2 116 123
22. Tortorelli S., Turgeon C. T., Lim J. S., et al. Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry. J Pediatr: 2010; 157 2 271 275
23. Baethmann M., Wendel U., Hoffmann G. F., et al. Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics: 2000; 31 6 314 317 (Pubitemid 32216613)
24. Schiff M., Benoist J. F., Tilea B., Royer N., Giraudier S., Ogier de Baulny H. Isolated remethylation disorders: do our treatments benefit patients? J Inherit Metab Dis: 2011; 34 1 137 145
25. Thauvin-Robinet C., Roze E., Couvreur G., et al. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry: 2008; 79 6 725 728 (Pubitemid 351829451)
26. Schiff M., Benoist J. F., Aïssaoui S., et al. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS ONE: 2011; 6 7 e21932
27. Farquharson J., Adams J. F. The forms of vitamin B12 in foods. Br J Nutr: 1976; 36 1 127 136
28. Rosenblatt D. S., Fenton W. A. Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver C. R., Beaudet A. L., Valle D., Sly W. S., eds. Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York McGraw-Hill: 2001; 3897 3933
29. Carmel R., Watkins D., Goodman S. I., Rosenblatt D. S. Hereditary defect of cobalamin metabolism (cblG mutation) presenting as a neurologic disorder in adulthood. N Engl J Med: 1988; 318 26 1738 1741
30. Schuh S., Rosenblatt D. S., Cooper B. A., et al. Homocystinuria and megaloblastic anemia responsive to vitamin B12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism. N Engl J Med: 1984; 310 11 686 690 (Pubitemid 14164644)
31. Harding C. O., Arnold G., Barness L. A., Wolff J. A., Rosenblatt D. S. Functional methionine synthase deficiency due to cblG disorder: a report of two patients and a review. Am J Med Genet: 1997; 71 4 384 390 (Pubitemid 27371834)
32. Mellman I., Willard H. F., Youngdahl-Turner P., Rosenberg L. E. Cobalamin coenzyme synthesis in normal and mutant human fibroblasts. Evidence for a processing enzyme activity deficient in cblC cells. J Biol Chem: 1979; 254 23 11847 11853 (Pubitemid 10187004)
33. Carrillo-Carrasco N., Sloan J., Valle D., Hamosh A., Venditti C. P. Hydroxocobalamin dose escalation improves metabolic control in cblC. J Inherit Metab Dis: 2009; 32 6 728 731
34. Andersson H. C., Shapira E. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). J Pediatr: 1998; 132 1 121 124 (Pubitemid 28082543)
35. Pentieva K., McNulty H., Reichert R., et al. The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men. J Nutr: 2004; 134 3 580 585 (Pubitemid 38298499)
36. Malouf R., Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev: 2008; 4 CD004514
37. Gregory J. F. III. Chemical and nutritional aspects of folate research: analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates. Adv Food Nutr Res: 1989; 33 1 101
38. Hyland K., Shoffner J., Heales S. J. Cerebral folate deficiency. J Inherit Metab Dis: 2010; 33 5 563 570
39. Wilcken B., Turner B. Homocystinuria. Reduced folate levels during pyridoxine treatment. Arch Dis Child: 1973; 48 1 58 62
40. Smulders Y. M., Smith D. E., Kok R. M., et al. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol: 2006; 132 5 623 629 (Pubitemid 43381597)
41. Verlinde P. H., Oey I., Hendrickx M. E., Van Loey A. M., Temme E. H. L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men. Eur J Clin Nutr: 2008; 62 10 1224 1230
42. Li D., Karp N., Wu Q., et al. Mefolinate (5-methyltetrahydrofolate), but not folic acid, decreases mortality in an animal model of severe methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis: 2008; 31 3 403 411
43. Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr: 1998; 157 02 S60 S66
44. Sibani S., Leclerc D., Weisberg I. S., et al. Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutation. Hum Mutat: 2003; 21 5 509 520 (Pubitemid 36529548)
45. Bendich A., Cohen M. Vitamin B6 safety issues. Ann N Y Acad Sci: 1990; 585 321 330
46. Hartmann H., Fingerhut M., Jakobs C., Plecko B. Status epilepticus in a neonate treated with pyridoxine because of a familial recurrence risk for antiquitin deficiency: pyridoxine toxicity? Dev Med Child Neurol: 2011; 53 12 1150 1153
47. Delgado-Reyes C. V., Wallig M. A., Garrow T. A. Immunohistochemical detection of betaine-homocysteine S-methyltransferase in human, pig, and rat liver and kidney. Arch Biochem Biophys: 2001; 393 1 184 186 (Pubitemid 32808374)
48. Smolin L. A., Benevenga N. J., Berlow S. The use of betaine for the treatment of homocystinuria. J Pediatr: 1981; 99 3 467 472 (Pubitemid 11029956)
49. Bartholomew D. W., Batshaw M. L., Allen R. H., et al. Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr: 1988; 112 1 32 39 (Pubitemid 18054264)
50. Allen R. H., Stabler S. P., Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism: 1993; 42 11 1448 1460 (Pubitemid 23335879)
51. Matthews A., Johnson T. N., Rostami-Hodjegan A., et al. An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. Br J Clin Pharmacol: 2002; 54 2 140 146 (Pubitemid 35024937)
52. Yaghmai R., Kashani A. H., Geraghty M. T., et al. Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am J Med Genet: 2002; 108 1 57 63
53. Yap S., Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis: 1998; 21 7 738 747 (Pubitemid 28477146)
54. Strauss K. A., Morton D. H., Puffenberger E. G., et al. Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab: 2007; 91 2 165 175 (Pubitemid 46765173)
55. Schwahn B. C., Laryea M. D., Chen Z., et al. Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency. Biochem J: 2004; 382 Pt 3 831 840 (Pubitemid 39312897)
56. Surtees R., Leonard J., Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet: 1991; 338 8782-8783 1550 1554
57. Abeling N. G., van Gennip A. H., Blom H., et al. Rapid diagnosis and methionine administration: basis for a favourable outcome in a patient with methylene tetrahydrofolate reductase deficiency. J Inherit Metab Dis: 1999; 22 3 240 242 (Pubitemid 29259485)
58. Al-Essa M. A., Al Amir A., Rashed M., et al. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography of the brain, MR spectroscopy, and therapeutic attempts in methylenetetrahydrofolate reductase deficiency. Brain Dev: 1999; 21 5 345 349 (Pubitemid 29299386)
59. Harpey J. P., Rosenblatt D. S., Cooper B. A., Le Moël G., Roy C., Lafourcade J. Homocystinuria caused by 5,10-methylenetetrahydrofolate reductase deficiency: a case in an infant responding to methionine, folinic acid, pyridoxine, and vitamin B12 therapy. J Pediatr: 1981; 98 2 275 278 (Pubitemid 11191089)
60. Wendel U., Bremer H. J. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr: 1984; 142 2 147 150 (Pubitemid 14120787)
61. Clayton P. T., Smith I., Harding B., Hyland K., Leonard J. V., Leeming R. J. Subacute combined degeneration of the cord, dementia and parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatry: 1986; 49 8 920 927 (Pubitemid 16048421)
62. Holme E., Kjellman B., Ronge E. Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child: 1989; 64 7 1061 1064 (Pubitemid 19177601)
63. Finkelstein J. D. Inborn errors of sulfur-containing amino acid metabolism. J Nutr: 2006; 136 6, Suppl 1750S 1754S (Pubitemid 43765391)
64. Stead L. M., Brosnan J. T., Brosnan M. E., Vance D. E., Jacobs R. L. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr: 2006; 83 1 5 10 (Pubitemid 44699227)
65. Huemer M., Simma B., Fowler B., Suormala T., Bodamer O. A., Sass J. O. Prenatal and postnatal treatment in cobalamin C defect. J Pediatr: 2005; 147 4 469 472 (Pubitemid 41446540)
66. Rosenblatt D. S., Cooper B. A., Schmutz S. M., Zaleski W. A., Casey R. E. Prenatal vitamin B12 therapy of a fetus with methylcobalamin deficiency (cobalamin E disease). Lancet: 1985; 1 8438 1127 1129 (Pubitemid 15080694)
67. Garlick P. J. Toxicity of methionine in humans. J Nutr: 2006; 136 6, Suppl 1722S 1725S (Pubitemid 43765387)
68. Coelho D., Kim J. C., Miousse I. R., et al. Mutations in ABCD4 cause a new inborn error of vitamin B(12) metabolism. Nat Genet: 2012; 44 10 1152 1155